HETEROCYCLIC COMPOUNDS AND METHODS OF USE

Compounds of the formula provide pharmacological agents which are potent agonists of Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the treatment of conditions mediated by the PPAR receptor activity in mammals. Such conditions...

Full description

Saved in:
Bibliographic Details
Main Authors VEDANANDA THALATHTHANI RALALAGE, LEE GEORGE TIEN-SAN, SABIO MICHAEL LLOYD, LOESER ERIC M, STANTON JAMES LAWRENCE, BACH ANDREW THOMAS, KAPA PRASAD KOTESWARA
Format Patent
LanguageEnglish
Polish
Published 04.04.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula provide pharmacological agents which are potent agonists of Peroxisome Proliferator-Activated Receptors (PPARs). Accordingly, the compounds of the instant invention are useful for the treatment of conditions mediated by the PPAR receptor activity in mammals. Such conditions include dyslipidemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity, inflammation, arthritis, cancer, Alzheimer's disease, skin disorders, respiratory diseases, ophthalmic disorders, inflammatory bowel diseases, ulcerative colitis and Crohn's disease. The compounds of the present invention are particularly useful in mammals as hypoglycemic agents for the treatment and prevention of conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X. Preferred are the compounds of the invention which are dual agonists of PPARα and PPARγ receptors.
Bibliography:Application Number: PL20020368637